Results 171 to 180 of about 7,333,462 (342)
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Beyond the linear model in concentration-QT analysis. [PDF]
Cellière G +3 more
europepmc +1 more source
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Addressing multicollinearity in general linear model: A novel approach for ridge parameter with performance comparison. [PDF]
Luqman M, Bhatti SH, Aydin D, Jamil M.
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Teacher-focused approach to foster student engagement - a hierarchical linear model based on Chinese college students' psychological capital. [PDF]
Hao XY, He Y, Zhang DX, Li XY.
europepmc +1 more source
Integrated partially linear model for multi-center studies with heterogeneity and batch effect in covariates. [PDF]
Yang L, Shao Y.
europepmc +1 more source

